Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 6Recruiting 3Withdrawn 1Unknown 1Terminated 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 1Lymphoma 1Intermittent Fasting 1Fasting 1

Interventions

Standard of Care 6Educational Status 6Interviews as Topic 5Practice Guidelines as Topic 3Patient Navigation 3Methods 3Exercise 3Early Intervention, Educational 3Weights and Measures 2Transcutaneous Electric Nerve Stimulation 2Resistance Training 2Music Therapy 2Magnetic Resonance Imaging 2Health Promotion 2Breathing Exercises 2venetoclax 1pembrolizumab 1camrelizumab 1apixaban 1Yoga 1Vitamin D 1Ultraviolet Therapy 1Transurethral Resection of Bladder 1Tramadol 1Thiamine 1Therapeutics 1Synbiotics 1Surgical Procedures, Operative 1Specimen Handling 1Sentinel Lymph Node Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Enrolling by invitation × Angptl4 protein, mouse × Clear all
NCT06645093 2026-03-10

FasteStudien

University of Oslo

Phase NA Enrolling by invitation
40 enrolled
Lymphoid

Intermittent Fasting, Fasting, Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡